Immunotherapy Combinations Are Being Explored in Bladder Cancer – Curetoday.com
Curetoday.com |
Immunotherapy Combinations Are Being Explored in Bladder Cancer
Curetoday.com Patients who are usually less likely to respond to immunotherapy [may harbor] FGFR alterations. FGFR is another target of another class of agents, pan-FGFR receptors, that are coming into the ground of bladder cancer treatment. The results of these … |
